Sign in

CIK 0001425205 · Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
753254381
Phone
6502607120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
  1. 4 Shares withheld for taxes Chief Medical Officer gave up 7,122 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Commercial Officer gave up 34,165 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Commercial Officer gave up 16,450 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Medical Officer gave up 6,448 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Operating Officer gave up 6,250 shares (to pay taxes)
  6. 4 Shares withheld for taxes Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,467 shares (to pay taxes)
  8. 4 Shares withheld for taxes Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,467 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Medical Officer gave up 6,448 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Operating Officer gave up 6,250 shares (to pay taxes)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy Chief Commercial Officer bought 30,000 shares at $1.84 ($55,200)

Page 3 of 18 · 352 filings